TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260951. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 4 | -99.1% | 0.00% | -100.0% |
| Q3 2016 | $82,000 | +43.9% | 459 | -14.0% | 0.01% | +50.0% |
| Q2 2016 | $57,000 | +1800.0% | 534 | +8800.0% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 6 | -14.3% | 0.00% | – |
| Q4 2015 | $1,000 | -80.0% | 7 | -68.2% | 0.00% | – |
| Q3 2015 | $5,000 | +400.0% | 22 | +100.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,033 | $708,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 18,400 | $126,000 | 0.00% |